| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.96e-05 | 120 | 27 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.43e-04 | 200 | 27 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.47e-04 | 430 | 27 | 5 | GO:0004175 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.65e-03 | 654 | 27 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 2.53e-03 | 431 | 27 | 4 | GO:0004984 | |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 1.65e-05 | 5 | 27 | 2 | GO:0045636 | |
| GeneOntologyBiologicalProcess | regulation of melanocyte differentiation | 3.45e-05 | 7 | 27 | 2 | GO:0045634 | |
| GeneOntologyBiologicalProcess | positive regulation of pigment cell differentiation | 3.45e-05 | 7 | 27 | 2 | GO:0050942 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental pigmentation | 5.91e-05 | 9 | 27 | 2 | GO:0048087 | |
| GeneOntologyBiologicalProcess | regulation of pigment cell differentiation | 5.91e-05 | 9 | 27 | 2 | GO:0050932 | |
| GeneOntologyBiologicalProcess | regulation of developmental pigmentation | 1.71e-04 | 15 | 27 | 2 | GO:0048070 | |
| GeneOntologyBiologicalProcess | regulation of pigmentation | 2.22e-04 | 17 | 27 | 2 | GO:0120305 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 5.23e-04 | 530 | 27 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.36e-03 | 656 | 27 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.38e-03 | 658 | 27 | 5 | GO:0030312 | |
| Domain | ADAM_spacer1 | 3.01e-08 | 23 | 27 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 3.01e-08 | 23 | 27 | 4 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.61e-08 | 24 | 27 | 4 | IPR013273 | |
| Domain | Peptidase_M12B_N | 2.75e-07 | 39 | 27 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.75e-07 | 39 | 27 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.05e-07 | 40 | 27 | 4 | PS00427 | |
| Domain | ADAM_MEPRO | 3.05e-07 | 40 | 27 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.05e-07 | 40 | 27 | 4 | PS50214 | |
| Domain | Reprolysin | 3.05e-07 | 40 | 27 | 4 | PF01421 | |
| Domain | Peptidase_M12B | 3.05e-07 | 40 | 27 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 3.38e-07 | 41 | 27 | 4 | IPR001762 | |
| Domain | TSP_1 | 1.95e-06 | 63 | 27 | 4 | PF00090 | |
| Domain | Pept_M12B_GON-ADAMTSs | 2.01e-06 | 2 | 27 | 2 | IPR012314 | |
| Domain | GON | 2.01e-06 | 2 | 27 | 2 | PF08685 | |
| Domain | GON | 2.01e-06 | 2 | 27 | 2 | PS51046 | |
| Domain | TSP1 | 2.21e-06 | 65 | 27 | 4 | SM00209 | |
| Domain | TSP1_rpt | 2.21e-06 | 65 | 27 | 4 | IPR000884 | |
| Domain | TSP1 | 2.21e-06 | 65 | 27 | 4 | PS50092 | |
| Domain | MetalloPept_cat_dom | 5.34e-06 | 81 | 27 | 4 | IPR024079 | |
| Domain | - | 5.34e-06 | 81 | 27 | 4 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 1.14e-05 | 98 | 27 | 4 | PS00142 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.35e-07 | 39 | 20 | 4 | MM15165 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.35e-07 | 39 | 20 | 4 | M27417 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.26e-06 | 68 | 20 | 4 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.49e-05 | 109 | 20 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.60e-05 | 111 | 20 | 4 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.34e-05 | 143 | 20 | 4 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.74e-04 | 250 | 20 | 4 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.22e-04 | 258 | 20 | 4 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.44e-04 | 300 | 20 | 4 | M610 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 9.66e-04 | 140 | 20 | 3 | M587 | |
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 24753090 | ||
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 21041365 | ||
| Pubmed | 5.59e-08 | 10 | 28 | 3 | 11167130 | ||
| Pubmed | 7.68e-08 | 11 | 28 | 3 | 33909046 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.02e-07 | 12 | 28 | 3 | 25770910 | |
| Pubmed | 2.60e-07 | 16 | 28 | 3 | 30579834 | ||
| Pubmed | 3.15e-07 | 17 | 28 | 3 | 22183742 | ||
| Pubmed | 3.93e-07 | 75 | 28 | 4 | 20637190 | ||
| Pubmed | 5.28e-07 | 20 | 28 | 3 | 19922873 | ||
| Pubmed | Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture. | 6.25e-07 | 2 | 28 | 2 | 20568084 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29137610 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23154421 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 12514189 | ||
| Pubmed | 9.35e-07 | 24 | 28 | 3 | 29791855 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 37169079 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23562508 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 3.28e-06 | 36 | 28 | 3 | 25615642 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 24220035 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 16507336 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 22562232 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 31600785 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 11831030 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 15599946 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 23354118 | ||
| Pubmed | PIBF1 regulates trophoblast syncytialization and promotes cardiovascular development. | 1.47e-05 | 59 | 28 | 3 | 38374152 | |
| Pubmed | The secreted metalloprotease ADAMTS20 is required for melanoblast survival. | 1.74e-05 | 8 | 28 | 2 | 18454205 | |
| Pubmed | 1.88e-05 | 64 | 28 | 3 | 22261194 | ||
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 32909945 | ||
| Pubmed | 8.44e-05 | 17 | 28 | 2 | 10464288 | ||
| Pubmed | 1.56e-04 | 23 | 28 | 2 | 29567669 | ||
| Pubmed | 1.56e-04 | 23 | 28 | 2 | 26027930 | ||
| Pubmed | 1.56e-04 | 23 | 28 | 2 | 30814516 | ||
| Pubmed | 1.85e-04 | 25 | 28 | 2 | 29475039 | ||
| Pubmed | Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. | 3.05e-04 | 32 | 28 | 2 | 21546767 | |
| Pubmed | 3.25e-04 | 33 | 28 | 2 | 32640236 | ||
| Pubmed | Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. | 4.32e-04 | 38 | 28 | 2 | 29743679 | |
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 4.32e-04 | 38 | 28 | 2 | 18267097 | |
| Pubmed | WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy. | 4.78e-04 | 40 | 28 | 2 | 29078390 | |
| Cytoband | 1q44 | 2.06e-03 | 110 | 28 | 2 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q21 | 2.53e-03 | 122 | 28 | 2 | chr21q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 2.78e-03 | 128 | 28 | 2 | chr1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q11 | 7.75e-03 | 217 | 28 | 2 | chr15q11 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 7.61e-09 | 19 | 23 | 4 | 50 | |
| GeneFamily | Olfactory receptors, family 2 | 8.99e-03 | 113 | 23 | 2 | 149 | |
| GeneFamily | EF-hand domain containing | 3.13e-02 | 219 | 23 | 2 | 863 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 184 | 27 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 184 | 27 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 184 | 27 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.04e-05 | 119 | 27 | 3 | d8fbea9ded96fcc3ebdfb4d28873c563427ce811 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.04e-05 | 119 | 27 | 3 | 9e38f13bf98b9ee44b178300e6f80fd08a006296 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 182 | 27 | 3 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 182 | 27 | 3 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.80e-04 | 183 | 27 | 3 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 186 | 27 | 3 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 27 | 3 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.95e-04 | 188 | 27 | 3 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.98e-04 | 189 | 27 | 3 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.98e-04 | 189 | 27 | 3 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 190 | 27 | 3 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 190 | 27 | 3 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 191 | 27 | 3 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | (7)_Epithelial-E_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.04e-04 | 191 | 27 | 3 | 0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-04 | 192 | 27 | 3 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.11e-04 | 193 | 27 | 3 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.14e-04 | 194 | 27 | 3 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.14e-04 | 194 | 27 | 3 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 196 | 27 | 3 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 198 | 27 | 3 | 85215015bb86ada0e871c413a4ecdc903a3785ca | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-04 | 198 | 27 | 3 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 198 | 27 | 3 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | Biopsy_IPF-Epithelial-AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 2.31e-04 | 199 | 27 | 3 | c841d475703d3489161fb7904526bd7563d5fb0f | |
| ToppCell | Biopsy_IPF-Epithelial-Transitional_AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 2.31e-04 | 199 | 27 | 3 | 83ff8b7e472d1212324c05cc719b746d19e5e23b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 199 | 27 | 3 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 199 | 27 | 3 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.34e-04 | 200 | 27 | 3 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.34e-04 | 200 | 27 | 3 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.34e-04 | 200 | 27 | 3 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 7.75e-07 | 227 | 23 | 5 | EFO_0004346, EFO_0010736 | |
| Disease | obesity (implicated_via_orthology) | 6.07e-04 | 215 | 23 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 7.98e-04 | 550 | 23 | 4 | EFO_0004346, EFO_0004464 | |
| Disease | Abnormality of refraction | 1.68e-03 | 673 | 23 | 4 | HP_0000539 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.08e-03 | 713 | 23 | 4 | EFO_0005689 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.02e-03 | 105 | 23 | 2 | DOID:9352 (implicated_via_orthology) | |
| Disease | corneal topography | 3.25e-03 | 109 | 23 | 2 | EFO_0004345 | |
| Disease | cortical surface area measurement | 3.31e-03 | 1345 | 23 | 5 | EFO_0010736 | |
| Disease | depressive symptom measurement | 4.27e-03 | 426 | 23 | 3 | EFO_0007006 | |
| Disease | acylcarnitine measurement | 4.38e-03 | 127 | 23 | 2 | EFO_0005059 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDVCARLWCAVVRQG | 511 | Q9UNA0 | |
| RLWCAVVRQGQMVCL | 516 | Q9UNA0 | |
| VIQQTMRGWARCVLP | 836 | Q96DT5 | |
| CCTVLLGLMQKNRRW | 406 | A6NHC0 | |
| LAACVVACVGLVWMQ | 81 | O75071 | |
| WEGCTKMCQGLQRRN | 856 | P59510 | |
| WMNCIRQARVRLQCK | 51 | P56750 | |
| MNQRLCCILVALSWR | 136 | A0A0X1KG70 | |
| CIVGWRCRVGQWVRM | 306 | Q9Y5P6 | |
| MATGCQSGLVCVWRI | 3691 | Q15751 | |
| MVCRIWRAILAQRAG | 1266 | O95382 | |
| MAAIRALQQWCRQQC | 1 | Q8IY33 | |
| MNQRLCCILVALSWR | 136 | Q8NGB6 | |
| APMVQGVITRRCCSW | 91 | H3BQJ8 | |
| MNQRVCQLLVSACWV | 141 | Q8NGX1 | |
| MNQRVCQLLVSACWV | 141 | Q8NH03 | |
| MWRLRRAAVACEVCQ | 1 | O60313 | |
| ALGNEMVCRGIWQCL | 266 | P47804 | |
| MVCRGIWQCLSPQKR | 271 | P47804 | |
| RRMCNIQECTHPLWV | 896 | O15072 | |
| MQCRRLWCNNVNGVH | 536 | Q9P2N4 | |
| LGMVVCNWVVILSVC | 136 | Q9Y4D2 | |
| QMWQLLVRVIVCRCN | 751 | O75309 | |
| TVLRCCRGWMQQPDE | 106 | O75095 | |
| LVSQNCCRASVVWMA | 26 | Q8WVZ7 | |
| LVNMFVRGCWVNGIR | 11 | Q5TGL8 | |
| GRVICRVIMPCNWWV | 296 | Q9H2S6 | |
| MNRSRQVTCVAWVRC | 1 | Q13610 | |
| EGCQCWRVITVPAML | 1366 | P08922 | |
| MLWRVCRGNVFLRQA | 186 | Q93050 |